In invasive carcinoma (Table 2), CD8+ and FOXP3+TIL infiltration as well as PD-L1+ immune cell infiltration was higher in CXCL10-positive tumors (p = 0.007, p = 0.001, and p = 0.001, respectively). The gene discussed is FOXP3; the disease is invasive carcinoma.